Latest updates for Weight Loss Drugs
Fresh curated links around weight loss drugs are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- FDA mulls weight loss drug controls
- New Weight Loss Drug Shows Surprising Results In Clinical Trials
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
New Weight Loss Drug Shows Surprising Results In Clinical Trials
Imagine shedding pounds like you just had gastric bypass—without the surgery. That’s the buzz around Eli Lilly’s new weight loss contender. Continue reading…
Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
MONDAY, July 13, 2026 — Weight-loss meds are transforming obesity treatment. But when it comes to heart health, exercise may still be the game changer. "The study shows that while...
Weight-Loss Drugs Are Next on the Chopping Block
Wall Street Journal: “Coverage for Ozempic and other drugs used for weight loss has fast become one of the most coveted workplace benefits—so much so that companies say they can no...
Experimental drug helps patients lose 85 pounds on average, study finds
Experimental drug retatrutide cut weight by nearly 30% in Phase 3 trials, outperforming approved therapies, Eli Lilly says.
A new wave of weight-loss therapies aims to be better than today’s GLP-1s
Retatrutide is one of those drugs. It helped people lose a massive amount of weight in clinical trials. It also improved sleep apnea and knee pain.
What Is Retatrutide? Dr. Dubrow Calls It the Most Powerful Weight-Loss Drug
The buzz around weight-loss drugs has never been louder or more exciting, especially when it comes to a brand new option called retatrutide or “reta”—stuff so powerful it’s basical...
Doctor loses 40kg, says weight-loss drugs require lifelong use
A doctor who lost 40 kilograms using GLP-1 weight-loss drugs said patients must remain on the medication to maintain weight loss, citing studies that show patients regain weight if...
Experimental Drug Yields Dramatic Weight Loss
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
This GLP-1 drug may be best for weight loss
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, researchers report.
More Americans Than Ever Are Taking Weight-Loss Drugs
The number of U.S. adults taking an obesity medication has nearly quadrupled from just two years ago.
People lost up to 85 pounds on Lilly's experimental weight loss drug, company says
Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker...
Weight loss drugs don't work for everyone—here’s why
Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight. The reason why may be genetics
People taking GLP-1 weight loss drugs like Ozempic started moving less
People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data...
Why Retatrutide Is Being Called The Next Frontier In Weight Loss Drugs
The world of weight management is evolving faster than ever, and a new drug discovery is setting a historic milestone for obesity treatment.
Research shows weight-loss drugs may also reduce cancer risk
A growing body of research suggests popular weight-loss drugs like Ozempic and Wegovy may also help treat or prevent certain cancers. It's the latest unexpected benefit to be assoc...
Weight loss drugs may literally be saving people's arms and legs
GLP-1 drugs like Ozempic and Wegovy are already known for treating type 2 diabetes and helping with weight loss. Now, a new study suggests they may also improve some of the most di...
A New Weight-Loss Drug Just Outperformed Popular GLP-1s. Here’s What It Means for the Future of Health
Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.
Weight-loss drug users save more than £400 a year on food as take-up triples
Research suggests households that include a GLP-1 user collectively spent £780m less on grocery billsBusiness live – latest updatesWeight-loss drugs are saving users’ households mo...
The Race to Build the Next Generation of Weight Loss Pills Is Heating Up
Multiple drug companies are developing GLP-1-based drugs that can be easily taken orally.
Some Medicare beneficiaries eligible for weight loss drug discounts
The number of Americans taking a GLP-1 drug for weight loss is on the rise. A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just tw...
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...
Trial of next-gen weight-loss drug retatrutide brings it one step closer to FDA approval
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three hormone receptors
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.